The receptor s1p1 overrides regulatory t cell–mediated immune suppression through akt-mtor

The receptor s1p1 overrides regulatory t cell–mediated immune suppression through akt-mtor

Play all audios:

Loading...

ABSTRACT Regulatory T cells (Treg cells) are critically involved in maintaining immunological tolerance, but this potent suppression must be 'quenched' to allow the generation of


adaptive immune responses. Here we report that sphingosine 1-phosphate (S1P) receptor type 1 (S1P1) delivers an intrinsic negative signal to restrain the thymic generation, peripheral


maintenance and suppressive activity of Treg cells. Combining loss- and gain-of-function genetic approaches, we found that S1P1 blocked the differentiation of thymic Treg precursors and


function of mature Treg cells and affected Treg cell–mediated immune tolerance. S1P1 induced selective activation of the Akt-mTOR kinase pathway to impede the development and function of


Treg cells. Dynamic regulation of S1P1 contributed to lymphocyte priming and immune homeostasis. Thus, by antagonizing Treg cell–mediated immune suppression, the lipid-activated


S1P1-Akt-mTOR pathway orchestrates adaptive immune responses. Access through your institution Buy or subscribe This is a preview of subscription content, access via your institution ACCESS


OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access $209.00 per year only $17.42 per issue Learn more Buy this article * Purchase on


SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about


institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS SSU72 IS A T-CELL RECEPTOR-RESPONSIVE MODIFIER THAT IS INDISPENSABLE FOR


REGULATORY T CELLS Article 13 April 2021 RETINOIC ACID SIGNALING ACTS AS A RHEOSTAT TO BALANCE TREG FUNCTION Article 17 May 2022 LYMPHOTOXIN LIMITS FOXP3+ REGULATORY T CELL DEVELOPMENT FROM


FOXP3LO PRECURSORS VIA IL-4 SIGNALING Article Open access 14 August 2024 REFERENCES * Sakaguchi, S., Yamaguchi, T., Nomura, T. & Ono, M. Regulatory T cells and immune tolerance. _Cell_


133, 775–787 (2008). Article  CAS  Google Scholar  * Zheng, Y. & Rudensky, A.Y. Foxp3 in control of the regulatory T cell lineage. _Nat. Immunol._ 8, 457–462 (2007). Article  CAS  Google


Scholar  * Campbell, D.J. & Ziegler, S.F. FOXP3 modifies the phenotypic and functional properties of regulatory T cells. _Nat. Rev. Immunol._ 7, 305–310 (2007). Article  CAS  Google


Scholar  * Tang, Q. & Bluestone, J.A. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. _Nat. Immunol._ 9, 239–244 (2008). Article  CAS  Google Scholar  *


Shevach, E.M. et al. The lifestyle of naturally occurring CD4+CD25+Foxp3+ regulatory T cells. _Immunol. Rev._ 212, 60–73 (2006). Article  CAS  Google Scholar  * Fontenot, J.D., Rasmussen,


J.P., Gavin, M.A. & Rudensky, A.Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. _Nat. Immunol._ 6, 1142–1151 (2005). Article  CAS  Google Scholar  * Liu, Y. et


al. A critical function for TGF-β signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells. _Nat. Immunol._ 9, 632–640 (2008). Article  CAS  Google Scholar  * Vignali,


D.A., Collison, L.W. & Workman, C.J. How regulatory T cells work. _Nat. Rev. Immunol._ 8, 523–532 (2008). Article  CAS  Google Scholar  * Pasare, C. & Medzhitov, R. Toll


pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. _Science_ 299, 1033–1036 (2003). Article  CAS  Google Scholar  * Yang, Y., Huang, C.T., Huang, X.


& Pardoll, D.M. Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance. _Nat. Immunol._ 5, 508–515 (2004). Article  CAS  Google


Scholar  * Peng, G. et al. Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function. _Science_ 309, 1380–1384 (2005). Article  CAS  Google Scholar  * Sutmuller, R.P. et al.


Toll-like receptor 2 controls expansion and function of regulatory T cells. _J. Clin. Invest._ 116, 485–494 (2006). Article  CAS  Google Scholar  * Liu, H., Komai-Koma, M., Xu, D. &


Liew, F.Y. Toll-like receptor 2 signaling modulates the functions of CD4+CD25+ regulatory T cells. _Proc. Natl. Acad. Sci. USA_ 103, 7048–7053 (2006). Article  CAS  Google Scholar  * Schwab,


S.R. & Cyster, J.G. Finding a way out: lymphocyte egress from lymphoid organs. _Nat. Immunol._ 8, 1295–1301 (2007). Article  CAS  Google Scholar  * Rosen, H. et al. Modulating tone: the


overture of S1P receptor immunotherapeutics. _Immunol. Rev._ 223, 221–235 (2008). Article  CAS  Google Scholar  * Rivera, J., Proia, R.L. & Olivera, A. The alliance of


sphingosine-1-phosphate and its receptors in immunity. _Nat. Rev. Immunol._ 8, 753–763 (2008). Article  CAS  Google Scholar  * Mandala, S. et al. Alteration of lymphocyte trafficking by


sphingosine-1-phosphate receptor agonists. _Science_ 296, 346–349 (2002). Article  CAS  Google Scholar  * Brinkmann, V. et al. The immune modulator FTY720 targets sphingosine 1-phosphate


receptors. _J. Biol. Chem._ 277, 21453–21457 (2002). Article  CAS  Google Scholar  * Matloubian, M. et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P


receptor 1. _Nature_ 427, 355–360 (2004). Article  CAS  Google Scholar  * Allende, M.L., Dreier, J.L., Mandala, S. & Proia, R.L. Expression of the sphingosine 1-phosphate receptor, S1P1,


on T-cells controls thymic emigration. _J. Biol. Chem._ 279, 15396–15401 (2004). Article  CAS  Google Scholar  * Chi, H. & Flavell, R.A. Cutting edge: regulation of T cell trafficking


and primary immune responses by sphingosine 1-phosphate receptor 1. _J. Immunol._ 174, 2485–2488 (2005). Article  CAS  Google Scholar  * Graler, M.H., Huang, M.C., Watson, S. & Goetzl,


E.J. Immunological effects of transgenic constitutive expression of the type 1 sphingosine 1-phosphate receptor by mouse lymphocytes. _J. Immunol._ 174, 1997–2003 (2005). Article  Google


Scholar  * Ishii, I., Fukushima, N., Ye, X. & Chun, J. Lysophospholipid receptors: signaling and biology. _Annu. Rev. Biochem._ 73, 321–354 (2004). Article  CAS  Google Scholar  *


Sawicka, E. et al. The sphingosine 1-phosphate receptor agonist FTY720 differentially affects the sequestration of CD4+/CD25+ T-regulatory cells and enhances their functional activity. _J.


Immunol._ 175, 7973–7980 (2005). Article  CAS  Google Scholar  * Fontenot, J.D., Dooley, J.L., Farr, A.G. & Rudensky, A.Y. Developmental regulation of Foxp3 expression during ontogeny.


_J. Exp. Med._ 202, 901–906 (2005). Article  CAS  Google Scholar  * Lio, C.W. & Hsieh, C.S. A two-step process for thymic regulatory T cell development. _Immunity_ 28, 100–111 (2008).


Article  CAS  Google Scholar  * Burchill, M.A. et al. Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire. _Immunity_ 28, 112–121 (2008).


Article  CAS  Google Scholar  * Fontenot, J.D. et al. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. _Immunity_ 22, 329–341 (2005). Article  CAS  Google


Scholar  * Powrie, F., Correa-Oliveira, R., Mauze, S. & Coffman, R.L. Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between


protective and pathogenic cell-mediated immunity. _J. Exp. Med._ 179, 589–600 (1994). Article  CAS  Google Scholar  * Theofilopoulos, A.N., Koundouris, S., Kono, D.H. & Lawson, B.R. The


role of IFN-γ in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity. _Arthritis Res._ 3, 136–141 (2001). Article  CAS  Google Scholar  * Fontenot, J.D., Gavin,


M.A. & Rudensky, A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. _Nat. Immunol._ 4, 330–336 (2003). Article  CAS  Google Scholar  * Sauer, S. et al. T


cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. _Proc. Natl. Acad. Sci. USA_ 105, 7797–7802 (2008). Article  CAS  Google Scholar  * Haxhinasto, S., Mathis, D.


& Benoist, C. The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. _J. Exp. Med._ 205, 565–574 (2008). Article  CAS  Google Scholar  * Knight, Z.A. et al. A


pharmacological map of the PI3-K family defines a role for p110α in insulin signaling. _Cell_ 125, 733–747 (2006). Article  CAS  Google Scholar  * Nombela-Arrieta, C. et al. A central role


for DOCK2 during interstitial lymphocyte motility and sphingosine-1-phosphate-mediated egress. _J. Exp. Med._ 204, 497–510 (2007). Article  CAS  Google Scholar  * Carlson, C.M. et al.


Kruppel-like factor 2 regulates thymocyte and T-cell migration. _Nature_ 442, 299–302 (2006). Article  CAS  Google Scholar  * Miyara, M. & Sakaguchi, S. Natural regulatory T cells:


mechanisms of suppression. _Trends Mol. Med._ 13, 108–116 (2007). Article  CAS  Google Scholar  * Ledgerwood, L.G. et al. The sphingosine 1-phosphate receptor 1 causes tissue retention by


inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics. _Nat. Immunol._ 9, 42–53 (2008). Article  CAS  Google Scholar  * Belkaid, Y., Piccirillo, C.A., Mendez, S.,


Shevach, E.M. & Sacks, D.L. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. _Nature_ 420, 502–507 (2002). Article  CAS  Google Scholar  * Lund, J.M.,


Hsing, L., Pham, T.T. & Rudensky, A.Y. Coordination of early protective immunity to viral infection by regulatory T cells. _Science_ 320, 1220–1224 (2008). Article  CAS  Google Scholar 


* Takabe, K., Paugh, S.W., Milstien, S. & Spiegel, S. “Inside-out” signaling of sphingosine-1-phosphate: therapeutic targets. _Pharmacol. Rev._ 60, 181–195 (2008). Article  CAS  Google


Scholar  * Bensinger, S.J. et al. Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells. _J. Immunol._ 172, 5287–5296 (2004). Article  CAS  Google Scholar  * Crellin,


N.K., Garcia, R.V. & Levings, M.K. Altered activation of AKT is required for the suppressive function of human CD4+CD25+ T regulatory cells. _Blood_ 109, 2014–2022 (2007). Article  CAS 


Google Scholar  * Sehrawat, S. & Rouse, B.T. Anti-inflammatory effects of FTY720 against viral-induced immunopathology: role of drug-Induced conversion of T cells to become Foxp3+


regulators. _J. Immunol._ 180, 7636–7647 (2008). Article  CAS  Google Scholar  * Daniel, C. et al. FTY720 ameliorates Th1-mediated colitis in mice by directly affecting the functional


activity of CD4+CD25+ regulatory T cells. _J. Immunol._ 178, 2458–2468 (2007). Article  CAS  Google Scholar  * Payne, S.G. et al. The immunosuppressant drug FTY720 inhibits cytosolic


phospholipase A2 independently of sphingosine-1-phosphate receptors. _Blood_ 109, 1077–1085 (2007). Article  CAS  Google Scholar  * Wan, Y.Y., Chi, H., Xie, M., Schneider, M.D. &


Flavell, R.A. The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function. _Nat. Immunol._ 7, 851–858 (2006). Article  CAS  Google


Scholar  * Mitchell, T.C. et al. Immunological adjuvants promote activated T cell survival via induction of Bcl-3. _Nat. Immunol._ 2, 397–402 (2001). Article  CAS  Google Scholar  * Menon,


S. et al. COP9 signalosome subunit 8 is essential for peripheral T cell homeostasis and antigen receptor-induced entry into the cell cycle from quiescence. _Nat. Immunol._ 8, 1236–1245


(2007). Article  CAS  Google Scholar  Download references ACKNOWLEDGEMENTS We thank A. Rudensky (University of Washington) for _Foxp3_gfp 'knock-in' mice; D. Hildeman (University


of Cincinnati) for dominant negative and constitutively active Akt retroviral constructs; S. Shrestha for help with genotyping; M. McGargill for help with the FTOC procedure; R. Cross and G.


Lennon for cell sorting; and D. Green and D. Vignali for scientific discussions and reagents. Supported by the US National Institutes of Health (H.C.), the Arthritis Foundation (H.C.), the


Arthritis National Research Foundation (H.C.), the American Lebanese Syrian Associated Charities (H.C.) and the Intramural Research Program of the National Institutes of Health, National


Institute of Diabetes and Digestive and Kidney Diseases (R.L.P.). AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Department of Immunology, St. Jude Children's Research Hospital, Memphis,


Tennessee, USA Guangwei Liu, Samir Burns, Gonghua Huang & Hongbo Chi * Animal Resources Center, St. Jude Children's Research Hospital, Memphis, Tennessee, USA Kelli Boyd * Genetics


of Development and Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA Richard L Proia * Howard Hughes


Medical Institute, New Haven, Connecticut, USA Richard A Flavell * Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA Richard A Flavell & Hongbo


Chi Authors * Guangwei Liu View author publications You can also search for this author inPubMed Google Scholar * Samir Burns View author publications You can also search for this author


inPubMed Google Scholar * Gonghua Huang View author publications You can also search for this author inPubMed Google Scholar * Kelli Boyd View author publications You can also search for


this author inPubMed Google Scholar * Richard L Proia View author publications You can also search for this author inPubMed Google Scholar * Richard A Flavell View author publications You


can also search for this author inPubMed Google Scholar * Hongbo Chi View author publications You can also search for this author inPubMed Google Scholar CONTRIBUTIONS G.L. designed and did


the experiments with cells and mice, analyzed data and contributed to writing the manuscript; S.B. did retroviral transduction of bone marrow cells and reconstitution and managed the mouse


colony; G.H. and S.B. contributed to real-time PCR analysis; K.B. analyzed and assigned scores to histology data; R.L.P. and R.A.F. provided animal models; and H.C. designed experiments,


analyzed data, wrote the manuscript and provided overall direction. CORRESPONDING AUTHOR Correspondence to Hongbo Chi. SUPPLEMENTARY INFORMATION SUPPLEMENTARY TEXT AND FIGURES Supplementary


Figures 1–19 (PDF 3117 kb) RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Liu, G., Burns, S., Huang, G. _et al._ The receptor S1P1 overrides regulatory


T cell–mediated immune suppression through Akt-mTOR. _Nat Immunol_ 10, 769–777 (2009). https://doi.org/10.1038/ni.1743 Download citation * Received: 23 December 2008 * Accepted: 21 April


2009 * Published: 31 May 2009 * Issue Date: July 2009 * DOI: https://doi.org/10.1038/ni.1743 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content:


Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative